Douglas Lane & Associates LLC Raises Stake in Corteva, Inc. $CTVA

Douglas Lane & Associates LLC lifted its position in Corteva, Inc. (NYSE:CTVA) by 3,476.0% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 197,862 shares of the company’s stock after acquiring an additional 192,329 shares during the quarter. Douglas Lane & Associates LLC’s holdings in Corteva were worth $15,364,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in CTVA. EFG International AG purchased a new stake in Corteva in the 2nd quarter valued at about $25,000. Compass Financial Management LLC bought a new stake in shares of Corteva during the 2nd quarter worth $25,000. Elevation Wealth Partners LLC boosted its holdings in shares of Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after buying an additional 261 shares during the last quarter. Clearstead Trust LLC purchased a new stake in Corteva during the second quarter worth about $31,000. Finally, N.E.W. Advisory Services LLC bought a new stake in Corteva in the second quarter worth about $33,000. 81.54% of the stock is owned by institutional investors.

Corteva Price Performance

Shares of Corteva stock traded down $0.52 during trading on Friday, hitting $13.23. 14,596,479 shares of the stock traded hands, compared to its average volume of 6,535,720. The stock has a market cap of $8.83 billion, a price-to-earnings ratio of 8.74, a PEG ratio of 1.25 and a beta of 0.57. The firm’s fifty day moving average is $72.79 and its 200-day moving average is $78.74. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52 week low of $11.74 and a 52 week high of $90.97.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period last year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts expect that Corteva, Inc. will post 1.69 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date was Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analysts Set New Price Targets

CTVA has been the topic of several research analyst reports. Citigroup upped their price objective on Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a research note on Thursday, September 17th. Bank of America boosted their price target on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday, July 20th. JPMorgan Chase & Co. upgraded shares of Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 price target on the stock in a research note on Tuesday. Zacks Research lowered shares of Corteva from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Finally, Argus restated a “buy” rating and set a $91.00 target price on shares of Corteva in a research report on Friday, September 18th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $64.00.

Key Stories Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: KeyBanc upgraded Corteva after the Vylor spinoff, arguing that the streamlined crop-protection business could generate “meaningful” earnings growth after 2027. The firm maintained an Overweight rating and a $17 price target, above the stock’s recent trading level. Corteva Could See Meaningful Earnings Growth After 2027
• Positive Sentiment: A Seeking Alpha analysis maintained a bullish view, citing Corteva’s constructive long-term growth and margin outlook. The completed separation may allow management and investors to value the remaining business more clearly. Corteva: A Buy On Constructive Growth And Margin Outlook
• Positive Sentiment: Unusually heavy call-option activity indicates that some traders are positioning for a potential rebound or upside move, although options activity alone does not establish a fundamental improvement. Investors Buy Large Volume of Corteva Call Options
• Neutral Sentiment: KeyCorp’s longer-term estimates project EPS of $1.15 in fiscal 2027, $1.30 in 2028 and $1.60 in 2029, while retaining an Overweight rating and $17 target. The estimates provide a positive valuation framework but are below the $1.69 consensus forecast for the current year. KeyCorp Corteva Estimates
• Negative Sentiment: Zacks Research downgraded Corteva from Hold to Strong Sell, adding pressure to the shares and highlighting continued skepticism about the post-spinoff crop-protection business. Corteva Downgraded by Zacks Research
• Negative Sentiment: Commentary from Jim Cramer was more favorable toward the newly separated Vylor seed business than Corteva’s remaining operations, suggesting that investors may view the crop-protection segment as the less attractive part of the breakup. Jim Cramer on Corteva’s Breakup

Corteva Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.